FindTrial
Sign In

To check for early resolution of symptoms in liver abscess after needle aspiration

Evaluation of efficacy of aspiration in Amebic liver abscess

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033892
Enrollment
80
Registered
2021-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A064- Amebic liver abscess

Interventions

Intervention1: needle aspiration: ultrasound guided needle aspiration will be done in liver abscess of 5- 10 cm on day 1 along with drug metronidazole. Control Intervention1: pharmacotherapy alone: on

Sponsors

Government Medical College and Hospital Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Radiologically confirmed diagnosis of Amebic liver abscess. 2) size of abscess 5-10 cm. 3) Amebic serology positive.

Exclusion criteria

Exclusion criteria: 1) Left lobe abscess 2)Impending rupture/ Ruptured abscess. 3)Multiple liver abscesses. 4)Any systemic organ failure or sepsis. 5)Patients with primary or secondary immunodeficiency e.g., AIDS, Post transplantation, Splenectomised patients, chemotherapy, or radiation therapy. 6)Pregnant women.

Design outcomes

Primary

MeasureTime frame
To observe the trends in the resolution of fever and pain abdomen ( Visual analogue scale )Timepoint: 5 days—

Secondary

MeasureTime frame
to observe normalization of leucocytosis; duration of hospitalization; treatment failure; rupture of abscess; and deathTimepoint: 5 days—

Countries

India

Contacts

Public ContactDr Pritam Singh

Government Medical College and Hospital Sector 32 Chandigarh

pritam_doc@yahoo.com9646121560

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026